ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea · Delayed Price · Currency is KRW
871.00
+2.00 (0.23%)
At close: Mar 6, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
Pharmaceutical Manufacturing and Sales | 62.69B | 62.97B | 68.88B | 57.56B | 65.36B | | | | | |
Pharmaceutical Manufacturing and Sales Growth | -0.44% | -8.57% | 19.66% | -11.93% | -3.22% | | | | | |
| 62.69B | 62.97B | 68.88B | 57.56B | 65.36B | | | | | |
| -0.44% | -8.57% | 19.66% | -11.93% | -3.22% | | | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 65.41B | 65.76B | 72.04B | 60.40B | 68.72B | | | | | |
| -0.52% | -8.72% | 19.27% | -12.11% | 39.11% | | | | | |
| 56.32M | 53.37M | 83.57M | 56.38M | 44.08M | | | | | |
| 5.53% | -36.14% | 48.21% | 27.91% | - | | | | | |
Elimination of Internal Transactions | -2.77B | -2.84B | -3.24B | -2.90B | -3.40B | | | | | |
| 62.69B | 62.97B | 68.88B | 57.56B | 65.36B | | | | | |
| -0.44% | -8.57% | 19.66% | -11.93% | -3.22% | | | | | |
Source: S&P Global Market Intelligence.